Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers.
Blizzard, T.A., Dininno, F., Morgan, J.D., Chen, H.Y., Wu, J.Y., Kim, S., Chan, W., Birzin, E.T., Yang, Y.T., Pai, L.Y., Fitzgerald, P.M., Sharma, N., Li, Y., Zhang, Z., Hayes, E.C., Dasilva, C.A., Tang, W., Rohrer, S.P., Schaeffer, J.M., Hammond, M.L.(2005) Bioorg Med Chem Lett 15: 107-113
- PubMed: 15582421 
- DOI: https://doi.org/10.1016/j.bmcl.2004.10.036
- Primary Citation of Related Structures:  
1XP1, 1XP6, 1XP9, 1XPC - PubMed Abstract: 
A series of dihydrobenzoxathiin SERAMs with alkylated pyrrolidine side chains or alkylated linkers was prepared. Minor modifications in the side chain or linker resulted in significant effects on biological activity, especially in uterine tissue.
Organizational Affiliation: 
Merck Research Laboratories, RY800-B116, PO Box 2000, Rahway, NJ 07065, USA. tim_blizzard@merck.com